Successful Termination of Atrial Flutter by Ibutilide During Pregnancy

Authors

  • THOMAS A. BURKART M.D., F.A.C.C.,

    1. Department of Medicine, Division of Cardiovascular Medicine, University of Florida Health Science Center, Gainesville, Florida
    Search for more papers by this author
  • JORDANA KRON M.D.,

    1. Department of Medicine, Division of Cardiovascular Medicine, University of Florida Health Science Center, Gainesville, Florida
    Search for more papers by this author
  • WILLIAM M. MILES M.D., F.A.C.C.,

    1. Department of Medicine, Division of Cardiovascular Medicine, University of Florida Health Science Center, Gainesville, Florida
    Search for more papers by this author
  • JAMIE B. CONTI M.D., F.A.C.C.,

    1. Department of Medicine, Division of Cardiovascular Medicine, University of Florida Health Science Center, Gainesville, Florida
    Search for more papers by this author
  • MARIO D. GONZALEZ M.D., F.A.C.C.

    1. Department of Medicine, Division of Cardiovascular Medicine, University of Florida Health Science Center, Gainesville, Florida
    Search for more papers by this author

Address for reprints: Thomas A. Burkart, M.D., F.A.C.C., 1600 SW Archer Road, Box 100277, Gainesville, FL 32610. Fax: 352-846-0314; e-mail: burkata@medicine.ufl.edu

Abstract

Sustained atrial fibrillation and atrial flutter during pregnancy are uncommon arrhythmias that can significantly complicate normal prenatal care. Direct current external cardioversion is the current method of terminating these arrhythmias. In practice, however, this technique is sometimes considered undesirable by both physician and patients due to the need for deep sedation or anesthesia. In the present study, we describe the use of ibutilide to safely terminate symptomatic persistent atrial flutter in a patient during her 24th week of pregnancy.

Ancillary